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The function ofG-protein-coupled receptors is tightly
modulated by the lipid environment. Long-timescale
molecular dynamics simulations (totaling 3 ms) of
the A2A receptor in cholesterol-free bilayers, with
and without the antagonist ZM241385 bound,
demonstrate the instability of helix II in the apo
receptor in cholesterol-poor membrane regions. We
directly observe that the effect of cholesterol binding
is to stabilize helix II against abuckling-typedeforma-
tion, perhaps rationalizing the observation that the
A2A receptor couples toGprotein only in thepresence
of cholesterol (Zezula and Freissmuth, 2008). The
results suggest a mechanism by which the A2A
receptor may function as a coincidence detector,
activating only in the presence of both cholesterol
and agonist. We also observed a previously hypothe-
sized conformation of the tryptophan ‘‘rotameric
switch’’ on helix VI in which a phenylalanine on helix
V positions the tryptophan out of the ligand binding
pocket.
INTRODUCTION
G-protein-coupled receptors (GPCRs) are responsible for trans-
ducing chemical signals across cell membranes in many diverse
physiological contexts, comprising the largest family of proteins
in the human genome. The exquisitely tuned specificity of
GPCRs makes them ideal targets for drugs, and indeed they
are the most frequent pharmacological target in signaling
contexts (Schwartz and Hubbell, 2008). The entire family shares
a structurally homologous seven-transmembrane helix topology,
with a high degree of sequence homology within GPCR subtypes.
Until recently however, the only GPCR that had been diffracted to
high resolution was bovine rhodopsin (Palczewski et al., 2000),
and so much of what was inferred about the function of GPCRs
was based on this one structure. Recently, however, several
other class A GPCRs have been diffracted to high resolution,
including the human A2A adenosine receptor (Jaakola et al.,1660 Structure 17, 1660–1668, December 9, 2009 ª2009 Elsevier L2008), a human b2 adrenergic receptor (Cherezov et al., 2007;
Rasmussen et al., 2007; Rosenbaum et al., 2007), a turkey b1
adrenergic receptor (Warne et al., 2008), a higher-resolution
structure of bovine rhodopsin (Okada et al., 2004), and bovine
opsin (Scheerer et al., 2008). The focus of the present work is
the A2A adenosine receptor, a pharmacologically important
receptor that modulates the dopaminergic response (Dunwiddie
and Masino, 2001; Jacobson and Gao, 2006). Because activation
of the A2A receptor generally results in inhibition, misfunction of
this GPCR is implicated in neurological disorders such Parkin-
son’s disease (Schapira et al., 2006) and epilepsy (During and
Spencer, 1992).
The sudden profusion of structural information on class A
GPCRs opens a window into the function of this exceptionally
important class of receptors. Of particular interest are questions
such as ‘‘How does a particular receptor attain specificity, both
for G-proteins and ligands?’’ and ‘‘What is the process by which
ligand binding leads to activation and binding of a G-protein to
the intracellular loops?’’ It is known that GPCR signaling (and
nonsignaling) is characterized by ligands with a spectrum of
activities, and consequently GPCR activation is hypothesized
to involve a number of conformational substates and intermedi-
ates (Kobilka and Deupi, 2007). Some of these substates have
been observed experimentally in rhodopsin (Altenbach et al.,
2008; Ruprecht et al., 2004; Scheerer et al., 2008), computation-
ally in rhodopsin (Grossfield et al., 2008), and recently by Dror
et al. in simulations of the b2 adrenergic receptor (Dror et al.,
2009). The observations made by Dror et al. were made possible
by recent algorithmic advances that allow molecular dynamics
(MD) simulations of modest-sized proteins on microsecond
timescales on commodity hardware (Bowers et al., 2006; Klepeis
et al., 2009).
In tandem with the recent progress in obtaining high-resolu-
tion structures of several class A GPCRs, work on membrane
proteins in general has made clear that specific protein-lipid
and protein-sterol interactions are often of critical importance
to the function of such proteins (Burger et al., 2000; Lee, 2004).
This is true for GPCRs, because activities of some class A
GPCRs have been demonstrated to be sensitive to cholesterol
concentration (Gimpl et al., 1997; Pucadyil and Chattopadhyay,
2004), including the A2A receptor (Zezula and Freissmuth, 2008).
In addition, structural (Hanson et al., 2008) and simulationtd All rights reserved
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strated specific lipid and sterol binding. It is therefore of great
current interest to investigate the specific functional role that is
played by lipids and sterols in GPCR signaling.
In the present work, microsecond-timescale simulations of the
A2A adenosine receptor yield insight into the structural rear-
rangements that occur upon binding of an antagonist. The simu-
lations predict that helix II is destabilized in the absence of
cholesterol, which opens a cleft between helices I and II allowing
entry of a lipid headgroup into the binding pocket, perhaps
contributing to inactivity of the receptor. The fact that the site
where the lipid gains entry to the binding pocket is in the same
location as a recently identified specific cholesterol binding site
on the b2 adrenergic receptor (Hanson et al., 2008) suggests
a hypothesis about the role of competition between lipid and
cholesterol in determining if the receptor is agonist-ready and
therefore primed for activation. We therefore performed simula-
tions with two cholesterol molecules bound at the cholesterol
binding site. In these simulations, helix II is markedly stabilized.
These results suggest a structural hypothesis about the role of
cholesterol in stabilizing the receptor, and lead us to suggest
several experiments to connect the structural hypothesis to
A2A activity as a function of cholesterol.
RESULTS
Closing of the Ionic Lock in Antagonist-Bound A2A
Before examining the results for the apo A2A receptor, we
present data based on the receptor as it was crystallized, with
the antagonist ZM241385 bound (Jaakola et al., 2008). These
data serve as a control for the apo study, and provide insight
into the conformation of the ionic lock under physiological
conditions. The ionic lock is the name given to a highly
conserved D/ERY motif at the intracellular ends of helices III
and VI. When closed, a salt bridge is formed that constrains
the ends of the two helices, maintaining the receptor in an
Figure 1. Ionic Lock Conformation in
ZM241385-Bound A2A
Following Dror et al. (2009), the ionic lock confor-
mation is assessed by the distance between
Glu2286.30 and Arg1023.50. The Ca distance is indi-
cated by the red circles; the distance between
the closest oxygen of Glu2286.30 and nitrogen of
Arg1023.50 is indicated by the violet triangles.
The black lines are the smoothed data as
described in methods. Distances observed in
two different crystal structures of inactive
rhodopsin (PDB codes 1U19 and 1L9H) are indi-
cated by the thick blue horizontal lines (see also
Figure S1).
inactive conformation (Ballesteros et al.,
2001). It was therefore surprising that
the ionic lock was broken in the crystal
structures of both the A2A (Jaakola
et al., 2008) and b2 (Rasmussen et al.,
2007) receptors bound to inactivating
ligands. In both the b2 (Cherezov et al.,
2007) and the A2A receptor structures, the highly flexible third
intracellular loop (ICL3) was stabilized by replacing it with T4
lysozyme, and in another structure of the b2 receptor by binding
it to a specifically engineered antibody (Rasmussen et al., 2007).
Based on microsecond timescale simulations of the b2 receptor,
Dror et al. rationalized the ionic lock conformation, demon-
strating that it closes when the T4 lysozyme is removed from
ICL3 (Dror et al., 2009).
The observation that the A2A receptor possesses much lower
constitutive activity in the absence of agonist than b2 leads
naturally to consideration of the ionic lock conformation in the
T4L-free A2A receptor. We therefore removed the T4L and con-
structed the missing loop using Prime, developed by Schro¨-
dinger, L.L.C., and performed molecular dynamics simulations
of the T4L-free A2A receptor in a palmitoyloleoylphosphatidylcho-
line bilayer with explicit water (details in Experimental Proce-
dures). We first studied the receptor as it was crystallized, with
the antagonist ZM241385 bound; results for the apo receptor
are presented in the next section. The data in Figure 1 demon-
strate stable closing of the ionic lock after about 375 ns. (Note
that absolute timescales must be interpreted with care, as dis-
cussed in Experimental Procedures.) The lock that forms in the
A2A appears to be tighter than that observed in the simulations
of the b2 receptor—the C
a distance fluctuates around 7 A˚,
whereas the same distance in the b2 system never samples
distances less than 8 A˚—as well as in crystal structures of inac-
tive rhodopsin. Also, the initial behavior is different from that
observed for the b2 system; the lock samples many nearly closed
conformations before forming stably, and takes about twice as
long to form. It is not clear at this point whether these differences
are significant, as the physical process is stochastic and is not
likely to behave precisely the same way from one closing event
to the next. However, it is noteworthy that in an independent
trajectory (see Figure S1 available online) the lock fluctuates
around the closed state, emphasizing the stochastic nature of
the process.Structure 17, 1660–1668, December 9, 2009 ª2009 Elsevier Ltd All rights reserved 1661
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In order to gain insight into the mechanism of inactivation
upon antagonist binding, we performed simulations of the A2A
receptor in which the ZM241385 ligand was removed. A great
deal of data have been collected on the movement of the
seven-transmembrane helices during activation, especially at
the cytoplasmic face, where exhaustive spin-labeling techniques
have mapped out in detail conformational changes associated
with activation (Altenbach et al., 1999, 2008). Here, however,
we are interested in movements within the binding pocket, as
we observed little change at the cytoplasmic face upon the tran-
sition from holo to apo, consistent with the observation that the
apo A2A receptor has no constitutive activity (Jaakola et al.,
2008). Information on critical sites for activation within the ligand
binding pocket, and their relative distances in the active and
inactive conformations, has been gathered by engineering metal
ion binding sites in the ligand pocket of the b2, neurokinin-1, and
k-opioid receptors (Schwartz et al., 2006), so that metal ions can
serve as either agonists (Elling et al., 1999) or antagonists (Elling
et al., 1995). In both cases, the data suggest that binding of either
type of ligand draws the pocket inward, though clearly the details
determine whether such motion results in activation.
Figure 2 demonstrates a very rapid and dramatic opening of
the binding pocket upon removal of the ZM241385, suggesting
that the ligand exerts considerable inward force via its contacts
with helices III, V, VI, and VII. The opening of the binding pocket
was also measured by computing its volume using SiteMap,
a tool available in the Schro¨dinger suite that estimates volumes
of binding pockets. In the holo simulation, the volume of the
binding pocket fluctuates around 376 A˚3, while in the apo
simulation the volume increases to 500 A˚3 and extends much
deeper into the protein. Most of the motion observed upon
removal of the ligand is localized to the binding pocket area,
which is roughly bounded on the intracellular side by the three
conserved prolines in helices V, VI, and VII. As far as we are
aware, no distance data are available for the extracellular ends
of the transmembrane (TM) helices for the apo receptor.
However, it is noteworthy that engineered metal ion binding sites
that activate other class A GPCRs draw helix III together with
either or both helices VI and VII, resulting in a corresponding
opening of the intracellular portions of the TM helices (Schwartz
et al., 2006; Schwartz and Hubbell, 2008). This process has been
conceptualized by Schwartz and coworkers as a rigid body
motion of the helices around the conserved proline kinks, the
so-called global toggle switch model (Elling et al., 2006;
Schwartz et al., 2006). Our data only consider the conformational
change associated with binding and unbinding of an antagonist,
and therefore cannot directly address the global toggle switch,
which is a model of activation. However, we do observe that
the conserved prolines in helices V, VI, and VII soften the helices
enough that the antagonist can draw the pocket significantly
inward compared to the apo receptor without activating the
receptor. Presumably a small molecule agonist that binds in
the space between the TM helices draws them in more tightly
than the antagonist ZM241385, a hypothesis that is supported
by the distance data from metal ion activation studies (Elling
et al., 2006; Elling et al., 1995; Elling et al., 1999) and the obser-
vations that agonists tend to be smaller than antagonists for this
class (Jacobson and Gao, 2006).1662 Structure 17, 1660–1668, December 9, 2009 ª2009 Elsevier LtRotation of Tryptophan Toggle Releases Helices II and VI
The highly conserved tryptophan residue on helix VI (position
246, numbering of amino acids is based on the human A2A
Figure 2. Opening of the Binding Pocket in Apo A2A
Panel A plots the distance between the extracellular ends of helices III and VII,
as measured by the separation between the Ca of Cys773.25 and Met2707.35.
The data for the apo receptor are indicated by red circles, and data for the
ZMA241385-bound receptor with violet triangles. Smoothed data are indi-
cated by thick black lines; the data were smoothed as in Figure 1. Panels B
and C show, respectively, views of the closed and open conformations of
the apo receptor, viewed from the extracellular side. The helices are color
coded: helix I (yellow), helix II (orange), helix III (cyan), helix IV (green), helix V
(blue), helix VI (red), helix VII (purple). The Ca of Cys773.25 and Met2707.35
are indicated by black spheres. Panel D overlays the open (solid) and closed
(transparent) conformations.d All rights reserved
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function as a rotameric switch (Shi et al., 2002), the position of
which affects the properties of the kink induced by the neigh-
boring proline. In the inactive conformation, Trp2466.48 is situ-
ated between helices III and VI (Figure 3A), but rotates out of
the binding pocket upon activation. Superscript X.YY denotes
Figure 3. Conformation of Trp246 Phe182,
and Val57 in Apo A2A
Panel A shows the Trp2466.48 rotated into the
space between helices III and VI, making a hydro-
phobic contact with Val552.44 on helix II. This is the
position of Trp2466.48 in the holo trajectory, and at
the beginning of the apo trajectory. After about
100 ns, Trp2466.48 rotates out of the pocket
between helices III and VI and makes an edge on
face aromatic interaction with the conserved
Phe1825.47 on helix V, as shown in panels B and
C. Panel C plots both the center of mass distance
between the phenol rings of each residue (black),
as well as the angle between the planes defined
by the phenol rings (red).
Figure 4. Comparison of Trp246 Rotameric
States in Apo and Holo A2A
The c1 rotamer of Trp246
6.48, defined by the amide
N – carbonyl C - Ca - Cb is plotted for both the apo
(black circles) and holo (red triangles) trajectories.
a residue on helix X at position YY relative
to the most highly conserved residue on
helix X, which is arbitrarily designated as
position 50, with numbers decreasing/
increasing toward the N/C terminus.
This convention follows that developed
by Ballesteros and Weinstein (1995).
Figure 4 demonstrates that in the
ZM241385-bound receptor, Trp2466.48
never changes rotameric state, as the
furan ring of the ligand constrains its
mobility. In the absence of the antago-
nist, however, Trp2466.48 samples both
gauche+ and trans configurations, though it never returns to its
original conformation. At 250 ns, interaction with Phe1825.47
(described shortly) pulls Trp2466.48 about 40 degrees beyond
the gauche+ conformer, maintaining this strained state for the
duration of the simulation. Rotation of Trp2466.48 is accompa-
nied by the breaking of a hydrophobic contact with Val552.44Structure 17, 1660–1668, December 9, 2009 ª2009 Elsevier Ltd All rights reserved 1663
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the receptor. Interestingly, the combination of Trp2466.48 and
Phe1825.47 on helix V samples conformations that are hypothe-
sized to be associated with the active conformation (Figures
3B and 3C). It has been suggested that the highly conserved
Phe1825.47 is positioned to form and edge-to-face aromatic
interaction with Trp2466.48, keeping it in its ‘‘active’’ rotameric
state (Schwartz et al., 2006). Indeed, mutation of the conserved
Phe1825.47 to Ala has been observed to eliminate the signaling of
the otherwise highly constitutively active ghrelin receptor
(Schwartz et al., 2006). Figure 3C clearly demonstrates that
Trp2466.48 does in fact spend the majority of the time in this
configuration. This begs the question, Why does the apo A2A
receptor possess no constitutive activity?
Figure 5. View of a Bound POPC Lipid from
the Extracellular Side
(A and B) After opening of the apo receptor, a gap
opens between helices I and II, and a POPC head-
group inserts into the ligand binding pocket after
about 200 ns, where it remains for the duration of
the simulation. The helices are color coded as in
Figure 2 (see also Figure S2).
Figure 6. Ionic Lock Conformation in Apo
Bound A2A
As in Figure 1, the ionic lock conformation is
assessed by the distance between Glu2286.30
and Arg1023.50. The Ca distance is indicated by
the red circles; the distance between the closest
oxygen of Glu2286.30 and nitrogen of Arg1023.50
is indicated by the violet triangles. The black lines
are the smoothed data as described in Experi-
mental Procedures. Distances observed in two
different crystal structures of inactive rhodopsin
(PDB codes 1U19 and 1L9H) are indicated by the
thick blue horizontal lines (see also Figure S1).
The Inactive, Apo Conformation
of A2A Is Stabilized in the Absence
of Cholesterol by a Specific
Lipid-Protein Interaction
A close look at helix II in Figure 2C and D
reveals that it has undergone a significant
change in conformation after the binding
pocket has opened and several hundred
nanoseconds have elapsed. As a result
of the loss of the stabilizing interaction
with Trp2466.48, the region of helix II
between Gly562.54 and a Pro612.59 becomes quite distorted,
as several hydrophobic side chains are pulled into the core of
the bilayer. A closer inspection reveals a striking development,
shown in Figure 5—a gap has opened between helices I and II,
and a lipid head group has inserted through the gap into
the empty, open binding site. The lipid remains there for the
duration of the simulation, prying apart the binding pocket
and stabilizing the open conformation. (Similar results were
obtained in independent simulations; Figure S2.). The data in
Figure 6 show that binding of the lipid holds the intracellular
ends of helices III and VI within 8 A˚ of each other, consistent
with an inactive receptor. However, the ionic lock forms only
transiently, as indicated by the N – O distance, which fluctuates
considerably more than in the ZM241385-bound receptor1664 Structure 17, 1660–1668, December 9, 2009 ª2009 Elsevier Ltd All rights reserved
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binding a lipid headgroup, stable formation of the ionic lock is
not required, instead the ends of helices III and VI are held in
close proximity, allowing transient formation of the lock.
Considering that a wide variety of ligands, from metal ions
(Schwartz et al., 2006) to small molecules (Jacobson and
Gao, 2006) to peptides (Schwartz, 1994), are able to inactivate
GPCRs by binding to various sites within the binding pocket
and on the extracellular loops (Schwartz, 1994), it seems
reasonable that an inactive conformation could be observed
without the ionic lock formed. This notion is also corroborated
by recent simulations of the b2 receptor (Dror et al., 2009)
and by an independent simulation of the ligand-bound A2A
receptor, in which the ionic lock is also transiently formed
(Figure S1). It ought to be stressed however that the events
observed are stochastic, and that the timescales simulated
are not sufficient to observe activation of the receptor, and so
these data are by themselves not conclusive evidence for an
inactivated state.
The lipid that inserts into the ligand binding site through the
gap between helices I and II sits in a pocket on the membrane-
exposed face of the receptor, between helices I, II, III, and IV—
a location which was predicted to be a cholesterol binding site
based on msec simulations of rhodopsin (Grossfield et al.,
2006), and recently observed to bind cholesterol on the b2
receptor (Hanson et al., 2008). The thermal stability of the b2
receptor was observed to increase in the presence of cholesterol
due to improved packing in the cholesterol binding pocket. More
than 40% of class A GPCRs are likely to specifically bind choles-
terol at this site, as evaluated by scanning sequences for a
cholesterol consensus motif that demands 3 residues to make
specific interactions with two cholesterols in the cholesterol
pocket. The A2A receptor in fact falls into an even more restrictive
set of GPCRs that possess an additional residue that makes
favorable interactions with the two cholesterols in the binding
pocket (Hanson et al., 2008). Also in this class are two other
receptors for which cholesterol greatly increases the affinity for
agonists (Gimpl et al., 1997; Pucadyil and Chattopadhyay,
2004). This shines a quite interesting light on the observation
that A2A does not couple to G proteins in the absence of choles-
terol (Zezula and Freissmuth, 2008).
Within the cell membrane the local concentration of choles-
terol is, of course, not constant. For those class A receptors
that possess the cholesterol binding motif, it may have evolved
as a coincidence detector (Zezula and Freissmuth, 2008), so
that the receptor is only active when both cholesterol and agonist
are present in sufficient quantity. The specific binding of a lipid
headgroup in the ligand pocket observed in the absence of
cholesterol in the present work would serve as a reversible
means of deactivating the receptor—then, upon moving from
a cholesterol-poor to a cholesterol-rich region, cholesterol
would compete for the binding site between helices I, II, and
III, displace the lipid, and prepare the receptor to receive an
agonist. Indeed, the presence of agonist would compete with
the lipid headgroup for binding in the ligand binding pocket,
perhaps simultaneously. We therefore performed calculations
with cholesterol bound in the site identified experimentally by
Hanson et al. (2008). Although a direct calculation of the free
energy difference between the cholesterol/lipid-bound confor-Structure 17, 1660–1mations is intractable for this system, we can investigate the
stability of helix II in the presence of cholesterol.
Helix II is Significantly Stabilized by Cholesterol Binding
in Apo A2A
We performed two independent simulations of apo A2A with
cholesterol bound in the binding site between helices I, II, and
III, in order to test the hypothesis that the cholesterol ‘‘protects’’
helix II from buckling, and prevents the entry of lipid headgroups
into the binding pocket through a gap between helices I and II.
The first observation is that the two cholesterols remain in the
cholesterol binding site during both simulations, and show no
indication that they will be displaced by lipid (Figure 7). The
two cholesterols make many contacts with helices I, II, and III,
and overall have the effect of stabilizing the receptor, as
measured by the average deviations from the initial structure.
The most dramatic increase in stability is observed in helix II
(Figure 8), for which much smaller positional fluctuations are
observed with cholesterol bound, as compared with the apo
simulation without cholesterol. Based on these data, our hypoth-
esis is that the specifically bound cholesterol stabilizes the
Figure 7. Cholesterol-Bound Apo A2A
The position of the two bound cholesterol molecules (space-filling representa-
tion) is stable in the binding site over the course of 800 ns simulation. The
protein is shown in surface representation, with helices I (yellow) II (orange)
and III (cyan) color coded, and the rest of the protein gray.668, December 9, 2009 ª2009 Elsevier Ltd All rights reserved 1665
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consistent with data recently published for the b2 receptor,
where it was observed that stability against denaturation is
increased by the presence of cholesterol (Hanson et al., 2008).
DISCUSSION
With molecular dynamics simulation timescales of microsec-
onds now within the reach of many research groups (Klepeis
et al., 2009), predictions about features like the rotameric states
of side chains become reliable, and the conformational rear-
rangements of small loops, turns, and helices become observ-
able. The present work follows recent successful predictions
by msec simulations of details of the activation of rhodopsin
(Grossfield et al., 2008; Martinez-Mayorga et al., 2006) and of
the dynamics of its ligand (Lau et al., 2007). The predictions of
any simulation must always be viewed with the understanding
that empirical force field development is an active area of
research, and so should be considered provisional until corrob-
orated by experiment and further simulation. We feel, however,
that the softening of helix II and insertion of a lipid at that location,
along with the observation that binding of cholesterol stiffens this
same helix and prevents the entry of a lipid headgroup into the
binding pocket merits consideration. One series of experiments
might be performed to look more carefully at the cholesterol
dependence of A2A activation. Zezula and Freissmuth have
mentioned that coupling of A2A to Gs requires cholesterol, but
it is not known to the authors whether this cholesterol depen-
dence has been explored in any detail. A first experiment would
examine the stability of the receptor as a function of choles-
terol—because we propose that cholesterol binding stabilizes
helix II, the receptor ought to be stabilized against chemical
denaturation by cholesterol. A second experiment would
examine the activity of the receptor as measured by G protein
binding as a function of cholesterol and agonist concentration.
Perhaps at sufficiently high cholesterol concentration, some
small constitutive activity of the receptor would be observed.
Finally, a test of the underlying structural hypothesis might be
performed by stiffening helix II, making it less likely to buckle
and invite a lipid to bind in cholesterol-poor membranes. If the
Figure 8. RMSD of Helix II Demonstrates
Stabilization by Bound Cholesterol
(A and B) The stability of helix II was assessed by
computing the root-mean-square deviation from
the 3EML structure of the heavy atoms of helix II,
after optimal alignment. The two APO-CHOL
simulations have cholesterol but not ZM241385
bound, the HOLO simulations have only
ZM241385 bound, and the APO simulations have
neither cholesterol nor ZM241385 bound.
bound lipid stabilizes the inactive form
while making it more challenging for an
agonist to bind, then stiffening helix II
should increase agonist binding effi-
ciency in the absence of cholesterol and
perhaps even introduce some constitu-
tive activity. Stiffening helix II might be
accomplished by mutating Gly562.54 to an Ala, greatly reducing
the volume of backbone conformational space at this key posi-
tion. Preliminary simulation data on this system are so far incon-
clusive, and will be continued in future work.
The present paper maintains that complementing GPCR
structural biology with high-performance computing deepens
our understanding of the stochastic events along the pathways
between active and inactive receptors. These results, other
simulations suggesting the importance of specific interactions
between rhodopsin and polyunsaturated fatty acids, and the
recent structure of the b2 receptor bound to two cholesterol
molecules all point to a rich future for studies focused on
modulation of GPCR activity by the lipid environment. Further
biochemical investigations and simulation studies will no doubt
add to the story of how the cell uses the lipid environment to
control signaling.
EXPERIMENTAL PROCEDURES
Initial structures were prepared from the 2.6 A˚ crystal structure of Protein Data
Bank (PDB) code 3EML (Jaakola et al., 2008). The T4 lysozyme was removed
and residues 149 to 155 and 311 to 326 were inserted using the Prime loop
building module from Schro¨dinger, L.L.C. The protein was embedded in a
palmitoyloleyolphosphatidylcholine bilayer by aligning the structure to the
orientations of proteins in membranes database (Lomize et al., 2006), with at
least 10 A˚ between the protein and its closest periodic image. The protein-
membrane system was solvated by approximately 16,500 SPC water mole-
cules in a simulation box of approximately 60 A˚ 3 80 A˚ 3 80 A˚, one Na+,
and 11 Cl-. The amber99 force field (Wang et al., 2000) was used to model
the protein, while the ligand, cholesterol, and lipids were parameterized
using the GAFF, with partial charges computed by the antechamber module
of the Amber simulation package (Case et al., 2008). All histidines were singly
protonated, all arginines and lysines were fully protonated. The area per lipid
was found to be in agreement with recent experimental results—without
application a surface tension. Details are in the Supplemental Experimental
Procedures. All the systems were relaxed using a 22 stage relaxation protocol
developed specifically for membrane protein systems, consisting of initial
minimization stages followed by slow heating and pressure coupling via
Berendsen thermostat and barostat, while releasing restraints on the
membrane and solute (membrane protein relaxation protocol from the Schro¨-
dinger 2009 suite developed by Dmitry Lupyan, unpublished work). Minimiza-
tions and molecular dynamics calculations were performed with Desmond
v20109 (Bowers et al., 2006), on 256 cores of the Ranger Sun Constellation1666 Structure 17, 1660–1668, December 9, 2009 ª2009 Elsevier Ltd All rights reserved
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Microsec Simulation of Apo A2A Adenosine ReceptorLinux Cluster, achieving approximately 50 ns/day of simulation time. The
systems were set up and relaxed using tools available in Maestro 8.5. All of
the following simulations were performed under constant pressure of 1 atm
and a temperature of 310 K, thermostatted and barostatted using the
Martyna-Tobias-Klein method (Martyna et al., 1994). Long-ranged electro-
statics were computed every third timestep by the particle mesh Ewald
method. The reader should note that the pressure/temperature control and
the use of multiple time-stepping renders timescales only informative in a rela-
tive sense; the determination of experimental timescales directly from the
simulation is not easily accomplished. For 1.3 ns, a Gaussian shaped barrier
potential was placed at the membrane/solvent interface, in order to prevent
solvent from entering the interior of the bilayer while the lipid relaxed around
the protein. At this point the barrier potential was removed and the simulation
was conducted free of restraints. The data presented here are for continuous
simulations of 930 ns (holo) and 720 ns (apo). In addition, two shorter simula-
tions of the holo system were performed totaling 780 ns, and two shorter
simulations of the apo system were performed totaling almost 1 ms.
All molecular images were created and analyses were performed with the
Visual Molecular Dynamics package, version 1.8.7alpha (Humphrey et al.,
1996). The smoothed distance data in Figures 1, 2, and 6 were calculated as
described in the supplementary information in Dror et al. (2009), by computing
a weighted average using one-half of a period of a sine function as the
weighting function, with a half-width of 1.2 ns.
SUPPLEMENTAL DATA
Supplemental Data include two figures and Supplemental Experimental
Procedures and can be found with this article online at http://www.cell.com/
structure/supplemental/S0969-2126(09)00413-4.
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